The two-line verdict: Navina synthesizes a patient's fragmented record into a point-of-care summary, surfaces care gaps and coding opportunities, and now spans pre-visit prep, ambient notes and audit-ready documentation. We score it 8.4/10: a credible, well-funded value-based-care copilot whose value depends on EHR integration depth and disciplined clinician review.

Overall
8.4
Strong, focused value-based-care copilot with real adoption
Features
8.7
Deep chart synthesis plus ambient documentation in one tool
Pricing
7.2
Enterprise-only; no public pricing to evaluate against
Ease of use
8.5
Sits inside existing workflows; minimal clinician training
Support
8.3
Clinical onboarding and customer-success teams reported
Integration
8.6
Connects to major EHRs and pulls structured + unstructured data

What is Navina?

Navina is an AI clinician copilot built for value-based care. It ingests a patient's scattered clinical history — structured EHR fields, lab results, claims data, and unstructured notes and faxes — and synthesizes it into a single, point-of-care patient profile that a physician can read in seconds rather than minutes. The product's core promise is to take the administrative weight off clinicians: instead of hunting through tabs and PDFs before a visit, the doctor opens Navina and sees a structured summary of what matters, the open care gaps, and the diagnoses that should be reviewed or documented. In a value-based contract, where reimbursement is tied to accurate risk capture and quality outcomes, that synthesis has direct financial as well as clinical value.

The company has expanded well beyond chart summarization. Over the past year Navina has built out an end-to-end workflow that spans pre-visit chart review, in-visit ambient note generation, and audit-ready documentation that supports correct coding and compliance. That positions it among the more complete healthcare AI agents on the market: it is not just an ambient scribe and not just a risk-adjustment tool, but a copilot that tries to cover the clinician's day from preparation through to the signed, defensible note.

Navina's traction is real and worth stating plainly. The company reports its copilot is used by more than 20,000 clinicians and care-team members, it raised a $55 million Series C led by Growth Equity at Goldman Sachs Alternatives (bringing total funding to roughly $100 million), and it won a 2026 Gold Stevie Award in the AI in Healthcare category. Navina also presented its platform around ViVE 2026, positioning itself explicitly as a clinician copilot for value-based care organizations.

Where Navina fits in the 2026 healthcare-AI market

The clinical AI market in 2026 splits roughly into ambient documentation tools, risk-adjustment and coding tools, and broader clinical copilots. Pure ambient scribes such as Abridge and Nabla concentrate on turning the conversation in the exam room into a structured note. Navina overlaps with that ambient layer but its center of gravity is different: it leads with chart synthesis and care-gap surfacing for value-based populations, then layers ambient documentation on top. Notably, Navina has worked with Nabla on ambient capabilities, which tells you the company is comfortable partnering for the scribe layer while it concentrates on the harder problem of making sense of a messy longitudinal record. Buyers weighing the broader scribe market should also read our Ambience vs Abridge comparison and our Abridge vs Nabla comparison to understand how the ambient-only tools differ.

Navina pricing in 2026

Navina does not publish pricing publicly. Like most enterprise clinical-AI platforms, it sells through a direct, sales-led motion with custom quotes scoped to the size of the organization, the number of clinicians, the modules deployed (chart synthesis, ambient documentation, coding support), the EHR integration work involved, and the services required for clinical onboarding. Pricing is not publicly disclosed, and we have not independently verified any specific figure, so we will not invent one.

What we can say is how to think about the cost. In a value-based context, the right lens is not seat price but return: improved risk-adjustment accuracy, captured-but-previously-missed diagnoses, closed care gaps, and time given back to clinicians. Navina's pitch to a medical group is that the platform pays for itself through more accurate coding and quality performance under the group's contracts. Any serious evaluation should ask the vendor for a scoped quote tied to your clinician count and contract mix, then model the expected lift against that number rather than comparing a sticker price.

Plan elementHow it is pricedNotes
Clinician copilotCustom, per organizationChart synthesis, care-gap surfacing, point-of-care profile
Ambient documentationCustom add-onIn-visit note generation
Coding & audit supportCustomRisk capture and audit-ready documentation
Implementation & onboardingQuoted with deploymentEHR integration and clinical change management

Pricing is not publicly disclosed by Navina; the table describes how enterprise clinical-AI tools are typically packaged and should be treated as directional only.

Pros

  • Synthesizes structured and unstructured records into a usable point-of-care summary
  • Purpose-built for value-based care, where accurate risk capture has direct ROI
  • End-to-end workflow: pre-visit prep, in-visit ambient notes, audit-ready documentation
  • Strong adoption (20,000+ clinicians) and credible funding signal stability
  • Designed to fit inside existing EHR workflows with minimal clinician retraining

Cons

  • No public pricing, so budgeting requires a sales conversation
  • Enterprise-focused; less suited to small independent practices
  • Value depends heavily on data quality and EHR integration depth
  • Care-gap and coding suggestions still require clinician review and accountability
  • Ambient scribe capability is newer than dedicated scribe specialists

Navina features reviewed in detail

Navina's value rests on four connected capabilities, and the way they fit together is more important than any single one. The first is data aggregation and synthesis. Clinical records are notoriously fragmented: the same patient may have structured problem lists, lab feeds, scanned consult letters, claims history, and free-text notes spread across systems. Navina pulls these together and reconstructs a coherent picture, extracting clinically meaningful facts from the unstructured material that would otherwise sit unread in a PDF. For a clinician walking into a complex chronic-care visit, this is the difference between ten minutes of chart archaeology and a thirty-second read.

The second capability is care-gap and diagnosis surfacing. Because Navina understands the longitudinal record, it can flag conditions that appear in the history but were never formally coded, suggest care gaps to close, and prompt the clinician to review diagnoses that are relevant to the visit. In value-based contracts, this is where the financial argument lives: undocumented but real chronic conditions mean the patient's risk is understated and the practice is underpaid for the care it provides. Navina's job is to surface those opportunities responsibly, as prompts for clinician judgment rather than automatic coding.

The third capability is ambient documentation. During the visit, Navina can generate a draft clinical note from the encounter, reducing the after-hours "pajama time" that drives so much clinician burnout. This is the same problem space occupied by dedicated ambient scribes, and Navina's approach — including its work with Nabla on ambient capability — reflects a pragmatic strategy of combining its chart-synthesis strength with a competent scribe layer rather than reinventing the entire stack.

The fourth capability is audit-ready documentation and coding support. It is not enough to surface a diagnosis; in a compliance-sensitive environment, the documentation has to support the code. Navina is designed to produce notes and supporting evidence that stand up to audit, which matters enormously for organizations operating under Medicare Advantage and other risk-bearing arrangements where coding accuracy is scrutinized. The honest caveat is that the clinician and the organization remain accountable for what is documented and billed; Navina is a tool that makes correct documentation easier, not a substitute for clinical and compliance oversight.

How Navina handles accuracy and clinician trust

The central risk with any clinical copilot is that it confidently surfaces something wrong — a misread lab, a hallucinated history, an inappropriate care-gap prompt. Navina's design philosophy leans on grounding its outputs in the actual record and presenting them as reviewable suggestions tied back to source data, so a clinician can verify a flag against the underlying note or result. This traceability is what separates a usable clinical tool from a liability. No buyer should deploy Navina, or any clinical AI, without validating its outputs on their own patient population and keeping a human firmly in the loop for every clinical and coding decision.

Integrations

Navina is built to live inside the clinician's existing environment rather than as a separate destination. It integrates with major electronic health record systems and ingests both structured data and unstructured documents, which is the technical precondition for everything else it does. For value-based-care organizations, integration with the EHR and with population-health and risk-adjustment workflows is the make-or-break factor, because a copilot that cannot reach the full record cannot synthesize it. Prospective buyers should confirm the depth of integration with their specific EHR and the exact data feeds available, since "integrates with EHRs" can mean anything from a deep bidirectional connection to a shallow read-only view.

Use cases

Navina is most compelling for medical groups, ACOs, and health systems operating under value-based or risk-bearing contracts. The clearest use case is pre-visit preparation for complex patients: a primary-care physician seeing a panel of chronically ill patients can walk into each visit already briefed, with care gaps and documentation opportunities surfaced. A second use case is accurate risk capture, where the platform helps ensure that real conditions are documented and coded so the organization is paid appropriately for the complexity it manages. A third is reducing documentation burden through ambient note generation, which addresses clinician burnout directly. A fourth is quality-program performance, where closing care gaps tied to quality measures improves both outcomes and contract performance.

Who it's for — and who should skip it

Navina is a strong fit for value-based-care organizations with the scale to integrate and govern an enterprise clinical platform, and the contract structures that reward accurate risk capture. If your reimbursement depends on documentation quality and care-gap closure, Navina targets your problem directly. It is a weaker fit for small independent fee-for-service practices that lack value-based contracts and the IT resources to support an enterprise deployment; those practices may get more immediate value from a focused ambient scribe. Organizations that need a pure documentation tool and nothing more should compare dedicated scribes such as Abridge before committing to Navina's broader platform.

Alternatives to Navina

Abridge

A market-leading ambient AI scribe with deep Epic integration, focused on turning the visit conversation into a structured note.

Read review →

Nabla

An ambient documentation assistant used across many specialties; Navina has partnered with Nabla on ambient capability.

Read review →

Ambience Healthcare

An enterprise ambient platform with strong coding-accuracy and revenue-lift positioning for large health systems.

See comparison →

Healthcare AI directory

Browse the full category to compare clinical copilots, scribes and risk tools side by side.

Browse category →

Verdict

Navina is one of the more complete clinician copilots aimed at value-based care, and it earns an 8.4/10. Its real differentiator is synthesis — turning a fragmented record into a point-of-care summary that surfaces the diagnoses and care gaps that drive both outcomes and reimbursement — wrapped in an end-to-end workflow that now reaches from pre-visit prep through ambient notes to audit-ready documentation. Strong adoption and a $55 million Series C reduce the platform-risk that often dogs clinical-AI buyers. The honest reservations are the lack of public pricing, the enterprise orientation that leaves small practices out, and the universal truth of clinical AI: its suggestions are only as trustworthy as the data behind them and the human review on top of them. For a value-based organization that can integrate and govern it well, Navina is a serious contender worth a scoped pilot.

Frequently asked questions

How much does Navina cost?

Navina does not publish pricing publicly. It sells through custom enterprise quotes based on organization size, clinician count, the modules deployed, EHR integration work, and onboarding services. Pricing is not publicly disclosed, so the only meaningful number is a scoped quote tied to your clinician count and contract mix. Evaluate it on return — accurate risk capture, closed care gaps, and time saved — rather than seat price.

What does Navina actually do?

Navina is an AI clinician copilot for value-based care. It aggregates a patient's structured and unstructured records into a single point-of-care summary, surfaces care gaps and documentation opportunities, generates ambient clinical notes during visits, and produces audit-ready documentation that supports accurate coding. The goal is to cut administrative burden while improving risk capture and quality performance.

Is Navina an ambient scribe like Abridge?

Not exactly. Navina leads with chart synthesis and care-gap surfacing for value-based populations and adds ambient documentation on top, including work with Nabla on ambient capability. Dedicated scribes such as Abridge and Nabla focus primarily on turning the exam-room conversation into a note. Navina overlaps with that layer but covers a broader workflow from pre-visit prep through audit-ready documentation.

How much funding has Navina raised?

Navina raised a $55 million Series C led by Growth Equity at Goldman Sachs Alternatives, bringing its total funding to roughly $100 million. The company also reports its copilot is used by more than 20,000 clinicians and care-team members and won a 2026 Gold Stevie Award in the AI in Healthcare category.

Which EHRs does Navina integrate with?

Navina integrates with major electronic health record systems and ingests both structured data and unstructured documents, which is what allows it to synthesize a complete patient picture. Because integration depth varies, prospective buyers should confirm exactly how Navina connects to their specific EHR and which data feeds are available before committing.

Who is Navina best for?

Navina is best for medical groups, ACOs, and health systems operating under value-based or risk-bearing contracts, where accurate documentation and care-gap closure have direct financial value and there are resources to integrate and govern an enterprise platform. Small independent fee-for-service practices usually get more immediate value from a focused ambient scribe.

Is Navina's output safe to rely on?

Navina grounds its suggestions in the actual record and presents them as reviewable prompts tied to source data, which supports clinician verification. But like all clinical AI, its outputs must be validated on your own patient population and kept human-led; the clinician and organization remain accountable for every clinical and coding decision.

Comparing options in this category? Browse our independent Healthcare AI Agents directory and head-to-head comparisons.

Evaluating Navina for your team? Talk to our editors →